Washington Drug Letter
April 23, 2012
| Vol.
44 No.
17
FDA Must Clarify Crude Heparin Definition in Guidance, Merck Says
The FDA must develop a clear and unambiguous definition of crude heparin in light of inconsistent and confusing uses of the term in its draft guidance, Merck says.
This article is viewable by subscribers only. To view this article, please select an option below.
|